<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
68016-715-01
</NDCCode>
<PackageDescription>
1 TUBE in 1 CARTON (68016-715-01) / 28 g in 1 TUBE
</PackageDescription>
<NDC11Code>
68016-0715-01
</NDC11Code>
<ProductNDC>
68016-715
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Triple Antibiotic Plus Pain Relief
</ProprietaryName>
<ProprietaryNameSuffix>
Maximum Strength
</ProprietaryNameSuffix>
<NonProprietaryName>
Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate And Pramoxine Hydrochloride
</NonProprietaryName>
<DosageFormName>
OINTMENT
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20150710
</StartMarketingDate>
<EndMarketingDate>
20261231
</EndMarketingDate>
<MarketingCategoryName>
OTC MONOGRAPH DRUG
</MarketingCategoryName>
<ApplicationNumber>
M004
</ApplicationNumber>
<LabelerName>
Chain Drug Consortium, LLC
</LabelerName>
<SubstanceName>
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
500; 3.5; 10000; 10
</StrengthNumber>
<StrengthUnit>
[USP'U]/g; mg/g; [USP'U]/g; mg/g
</StrengthUnit>
<Pharm_Classes>
Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-07-03
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
20150710
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20261231
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>